Skip to content

Feasibility and acceptability study of a new positive psychology intervention (*Living well with a chronic mental health disorder*) for people with chronic depression or chronic anxiety

Feasibility and acceptability study of a new positive psychology intervention (*Living well with a chronic mental health disorder*) for people with chronic depression or chronic anxiety - Living well with a chronic mental health disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49861
Enrollment
24
Registered
2021-06-02
Start date
2021-11-22
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety and depression well-being and recovery

Interventions

We aim to adapt the multicomponent positive psychology intervention *living well with a chronic mental health disorder* as a group intervention for patients with therapy-resistant anxiety of depress

Sponsors

Mediant (Enschede)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients are eligible between 18 and 75 years who are in treatment > 2 years for anxiety or depressive disorder, who still have residual complaints, counted with the Generalized Anxiety Disorder (GAD-7) and Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR). A cut-off score of 8 points on the GAD-7 for panic disorder, social phobia and PTSS indicates at least moderate complaints (Kroenke et al, 2007) and a cut-off score of 10 is used for all other anxiety disorders (Spitzer et al, 2006). A cut-off score of 11 points on the QIDS-SR indicates at least moderate depressive symptomatology. Participants must have the ability to speak and read the Dutch language and are willing to complete questionnaires before and after the treatment.

Exclusion criteria

Exclusion criteria: Participants scoring high on suicide risk, substance use disorders, and a lifetime diagnosis of bipolar disorder or schizophrenia are excluded for the treatment. Patients are also excluded when they are in individual treatment, when they do not speak the Dutch language, have an unstable, severe medical condition, have severe brain injury or have other cognitive impairments which makes them unable to attend the group intervention or had a change in pharmacological treatment in the past 6 weeks.

Design outcomes

Primary

MeasureTime frame
Well-being (primary outcome) is measured with the Mental Health Continuum - Short Form and Personal Recovery (primary outcome) Is measured with the Questionnaire about the Process of Recovery).

Secondary

MeasureTime frame
Secondary outcomes include personal recovery (measured with the Questionnaire about the Process of Recovery), social role participation (Social Role participation Questionnaire), self-compassion (Self-compassion Scale - Short Form), depressive symptoms (Quick - Inventory of Depressive Symptomatology, and anxiety General Anxiety Disorder -7.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)